Vanda Pharmaceuticals (VNDA) Treasury Shares (2010 - 2026)

Vanda Pharmaceuticals (VNDA) has 17 years of Treasury Shares data on file, last reported at $4.2 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 26.67% year-over-year to $4.2 million; the trailing twelve-month figure through Mar 2026 stood at $4.2 million (up 26.67% YoY), and the FY2025 full-year result was $3.5 million, up 31.19% from the prior year.
• Treasury Shares advanced to $4.2 million in Q1 2026, from $3.5 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $4.2 million in Q1 2026 to a low of $1.9 million in Q4 2023.
• A 5-year average of $2.6 million and a median of $2.7 million in 2024 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares decreased 2.33% in 2023 and surged 42.05% in 2024, its largest moves.
• Tracing VNDA's Treasury Shares over 5 years: stood at $1.9 million in 2022, then slipped by 0.53% to $1.9 million in 2023, then soared by 39.09% to $2.7 million in 2024, then jumped by 31.19% to $3.5 million in 2025, then increased by 21.49% to $4.2 million in 2026.
• Business Quant data shows VNDA's Treasury Shares at $4.2 million in Q1 2026, $3.5 million in Q4 2025, and $3.5 million in Q3 2025.